menu
    • menu

    Company profile for Difgen

    NEW Drugs in Dev: 3
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Difgenindia-flag Flag
    Country
    Country
    India
    Address
    Address
    5-35/189-A, 100 Ft. Road, Prashanthi Nagar, I.E. Kukatpally, Hyderabad - 50007...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://difgen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    DifGen Pharma, Aveva Lead U.S. PASC Immune Therapy Collaboration
    DifGen Pharma, Aveva Lead U.S. PASC Immune Therapy Collaboration

    25 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/difgen-pharmaceuticals-and-aveva-drug-delivery-systems-lead-us-technology-transfer-and-platform-development-collaboration-for-multi-indication-immune-restoration-therapy-with-active-ind-programs-and-phase-2b3-authorization-in-p-302724179.html

    PR NEWSWIRE
    25 Mar 2026
    Share Share
    FDA Approves DifGen's Generic Mesalamine ER (250mg/500mg)
    FDA Approves DifGen's Generic Mesalamine ER (250mg/500mg)

    11 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/difgen-pharmaceuticals-receives-fda-approval-for-generic-mesalamine-extended-release-capsules-usp-250mg-and-500mg-302710437.html

    PR NEWSWIRE
    11 Mar 2026
    Share Share
    Difgen Pharms’ Generics Mesalamine Receives Approval in US
    Difgen Pharms’ Generics Mesalamine Receives Approval in US

    10 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219997

    FDA
    10 Mar 2026
    Share Share
    Difgen Pharma Secures FDA Approval for Fluorometholone Eye Drops
    Difgen Pharma Secures FDA Approval for Fluorometholone Eye Drops

    13 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/difgen-pharmaceuticals-llc-receives-usfda-approval-for-fluorometholone-ophthalmic-suspension-0-1---expanding-its-complex-generic-portfolio-302686873.html

    PR NEWSWIRE
    13 Feb 2026
    Share Share
    Difgen Pharms’ Generics Fluorometholone Receives Approval in US
    Difgen Pharms’ Generics Fluorometholone Receives Approval in US

    12 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218819

    FDA
    12 Feb 2026
    Share Share
    DifGen Acquires FDA-Registered Finished Dosage Manufacturing Facility in Florida
    DifGen Acquires FDA-Registered Finished Dosage Manufacturing Facility in Florida

    18 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/difgen-pharmaceuticals-acquires-the-operating-and-manufacturing-assets-of-an-fda-registered-finished-dosage-manufacturing-facility-in-florida-enhancing-its-manufacturing-footprint-in-the-united-states-with-the-addition-of-manufac-302091478.html

    PR NEWSWIRE
    18 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search